Jane Henderson, Chief Financial Officer at Apogee Therapeutics, Inc. (APGE), sold 2,000 shares at $66.15 ($132K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Scheduled sale ($132k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.21 | 792 | $52K | 39.2% |
| 2 | $66.15 | 1,108 | $73K | 55.7% |
| 3 | $66.89 | 100 | $7K | 5.1% |
| Total | $65.81 avg | 2,000 | $132K | 100% |
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |